190 related articles for article (PubMed ID: 22657157)
1. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
Zulian F; Vallongo C; Patrizi A; Belloni-Fortina A; Cutrone M; Alessio M; Martino S; Gerloni V; Vittadello F; Martini G
J Am Acad Dermatol; 2012 Dec; 67(6):1151-6. PubMed ID: 22657157
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
Zulian F; Martini G; Vallongo C; Vittadello F; Falcini F; Patrizi A; Alessio M; La Torre F; Podda RA; Gerloni V; Cutrone M; Belloni-Fortina A; Paradisi M; Martino S; Perilongo G
Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Kroft EB; Creemers MC; van den Hoogen FH; Boezeman JB; de Jong EM
Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric localized scleroderma with methotrexate.
Fitch PG; Rettig P; Burnham JM; Finkel TH; Yan AC; Akin E; Cron RQ
J Rheumatol; 2006 Mar; 33(3):609-14. PubMed ID: 16511930
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F; Martini G
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1259-1263. PubMed ID: 32433808
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
[TBL] [Abstract][Full Text] [Related]
8. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J;
Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
11. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
Koch SB; Cerci FB; Jorizzo JL; Krowchuk DP
J Dermatolog Treat; 2013 Dec; 24(6):435-8. PubMed ID: 23758214
[TBL] [Abstract][Full Text] [Related]
12. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
Inamo Y; Ochiai T
Pediatr Dermatol; 2013; 30(6):e191-3. PubMed ID: 23025697
[TBL] [Abstract][Full Text] [Related]
13. Congenital localized scleroderma.
Zulian F; Vallongo C; de Oliveira SK; Punaro MG; Ros J; Mazur-Zielinska H; Galea P; Da Dalt L; Eichenfield LF
J Pediatr; 2006 Aug; 149(2):248-51. PubMed ID: 16887444
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma in children: an update.
Zulian F; Cuffaro G; Sperotto F
Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
[TBL] [Abstract][Full Text] [Related]
17. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
18. Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.
Schanz S; Henes J; Ulmer A; Kötter I; Fierlbeck G; Claussen CD; Horger M
AJR Am J Roentgenol; 2013 Apr; 200(4):W376-82. PubMed ID: 23521481
[TBL] [Abstract][Full Text] [Related]
19. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
20. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
